268 related articles for article (PubMed ID: 30698723)
1. Gas Chromatography-Mass Spectrometry Method for the Quantitative Identification of 23 New Psychoactive Substances in Blood and Urine.
Nisbet LA; Wylie FM; Logan BK; Scott KS
J Anal Toxicol; 2019 Jun; 43(5):346-352. PubMed ID: 30698723
[TBL] [Abstract][Full Text] [Related]
2. Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
Nisbet LA; Venson R; Wylie FM; Scott KS
J Anal Toxicol; 2017 Jul; 41(6):559-565. PubMed ID: 28830123
[TBL] [Abstract][Full Text] [Related]
3. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
[TBL] [Abstract][Full Text] [Related]
4. Death after 25C-NBOMe and 25H-NBOMe consumption.
Morini L; Bernini M; Vezzoli S; Restori M; Moretti M; Crenna S; Papa P; Locatelli C; Osculati AMM; Vignali C; Groppi A
Forensic Sci Int; 2017 Oct; 279():e1-e6. PubMed ID: 28893436
[TBL] [Abstract][Full Text] [Related]
5. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of 25B-, 25C-, 25D-, 25H-, 25I- and 25T2-NBOMe via LC-MS-MS: method validation and analyte stability.
Johnson RD; Botch-Jones SR; Flowers T; Lewis CA
J Anal Toxicol; 2014 Oct; 38(8):479-84. PubMed ID: 25217535
[TBL] [Abstract][Full Text] [Related]
8. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
9. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
[TBL] [Abstract][Full Text] [Related]
10. Determination of New Psychoactive Substances in Whole Blood Using Microwave Fast Derivatization and Gas Chromatography/Mass Spectrometry.
Cláudia M; Pedro A; Tiago R; Francisco CR; Eugenia G
J Anal Toxicol; 2020 Jan; 44(1):92-102. PubMed ID: 31436798
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.
Poklis JL; Clay DJ; Poklis A
J Anal Toxicol; 2014 Apr; 38(3):113-21. PubMed ID: 24535338
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.
Wiergowski M; Aszyk J; Kaliszan M; Wilczewska K; Anand JS; Kot-Wasik A; Jankowski Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():1-10. PubMed ID: 27992785
[TBL] [Abstract][Full Text] [Related]
13. A Validated Method for the Detection of 32 Bath Salts in Oral Fluid.
Williams M; Martin J; Galettis P
J Anal Toxicol; 2017 Oct; 41(8):659-669. PubMed ID: 28985394
[TBL] [Abstract][Full Text] [Related]
14. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials.
Strano Rossi S; Odoardi S; Gregori A; Peluso G; Ripani L; Ortar G; Serpelloni G; Romolo FS
Rapid Commun Mass Spectrom; 2014 Sep; 28(17):1904-16. PubMed ID: 25088134
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.
Poklis JL; Charles J; Wolf CE; Poklis A
Biomed Chromatogr; 2013 Dec; 27(12):1794-800. PubMed ID: 23893863
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive HPLC-MS-MS Screening Method for 77 New Psychoactive Substances, 24 Classic Drugs and 18 Related Metabolites in Blood, Urine and Oral Fluid.
Trana AD; Mannocchi G; Pirani F; Maida N; Gottardi M; Pichini S; Busardò FP
J Anal Toxicol; 2020 Dec; 44(8):769-783. PubMed ID: 32816015
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
19. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.
Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL
Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082
[TBL] [Abstract][Full Text] [Related]
20. Sewage-based epidemiology in monitoring the use of new psychoactive substances: Validation and application of an analytical method using LC-MS/MS.
Kinyua J; Covaci A; Maho W; McCall AK; Neels H; van Nuijs AL
Drug Test Anal; 2015 Sep; 7(9):812-8. PubMed ID: 25655588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]